- Home
- ARQT vs ETY Comparison
ARQT vs ETY Comparison
Compare ARQT & ETY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- ETY
- Stock Information
- Founded
- ARQT 2016
- ETY 2006
- Country
- ARQT United States
- ETY United States
- Employees
- ARQT N/A
- ETY N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- ETY Finance Companies
- Sector
- ARQT Health Care
- ETY Finance
- Exchange
- ARQT Nasdaq
- ETY Nasdaq
- Market Cap
- ARQT 2.1B
- ETY 2.5B
- IPO Year
- ARQT 2020
- ETY N/A
- Fundamental
- Price
- ARQT $17.71
- ETY $15.84
- Analyst Decision
- ARQT Strong Buy
- ETY
- Analyst Count
- ARQT 7
- ETY 0
- Target Price
- ARQT $19.00
- ETY N/A
- AVG Volume (30 Days)
- ARQT 1.6M
- ETY 247.3K
- Earning Date
- ARQT 11-05-2025
- ETY 01-01-0001
- Dividend Yield
- ARQT N/A
- ETY 7.21%
- EPS Growth
- ARQT N/A
- ETY N/A
- EPS
- ARQT N/A
- ETY N/A
- Revenue
- ARQT $263,464,999.00
- ETY N/A
- Revenue This Year
- ARQT $72.46
- ETY N/A
- Revenue Next Year
- ARQT $31.69
- ETY N/A
- P/E Ratio
- ARQT N/A
- ETY N/A
- Revenue Growth
- ARQT 99.50
- ETY N/A
- 52 Week Low
- ARQT $8.03
- ETY $10.59
- 52 Week High
- ARQT $18.15
- ETY $13.46
- Technical
- Relative Strength Index (RSI)
- ARQT 63.97
- ETY 51.41
- Support Level
- ARQT $16.62
- ETY $15.70
- Resistance Level
- ARQT $18.15
- ETY $16.03
- Average True Range (ATR)
- ARQT 0.69
- ETY 0.14
- MACD
- ARQT 0.03
- ETY -0.02
- Stochastic Oscillator
- ARQT 85.57
- ETY 55.81
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.